Holen Sie sich die Stockscreener-App
21.35
0.76%
0.16
Schlusskurs vom Vortag:
$21.19
Offen:
$21.29
24-Stunden-Volumen:
469.50K
Relative Volume:
0.90
Marktkapitalisierung:
$1.01B
Einnahmen:
$723.55M
Nettoeinkommen (Verlust:
$157.72M
KGV:
7.1167
EPS:
3
Netto-Cashflow:
$170.15M
1W Leistung:
+0.80%
1M Leistung:
-13.07%
6M Leistung:
-40.92%
1J Leistung:
-47.50%
1-Tages-Spanne:
$21.08
$21.70
1-Wochen-Bereich:
$20.43
$22.00
52-Wochen-Spanne:
$20.43
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Firmenname
Amphastar Pharmaceuticals Inc
Sektor
Telefon
909-980-9484
Adresse
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Vergleichen Sie AMPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
21.35 | 998.41M | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2023-07-25 | Fortgesetzt | Jefferies | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-07-29 | Eingeleitet | CapitalOne | Overweight |
| 2022-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Eingeleitet | Northland Capital | Outperform |
| 2019-03-13 | Herabstufung | Needham | Buy → Hold |
| 2019-03-13 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Bestätigt | Needham | Buy |
| 2018-03-13 | Bestätigt | Needham | Buy |
| 2017-12-01 | Bestätigt | Needham | Buy |
| 2017-11-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Bestätigt | Needham | Buy |
| 2017-03-14 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-05-10 | Bestätigt | Needham | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2015-06-19 | Bestätigt | Needham | Buy |
| 2015-06-03 | Eingeleitet | Raymond James | Strong Buy |
| 2014-07-21 | Eingeleitet | Needham | Buy |
Alle ansehen
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
What analysts say about Amphastar Pharmaceuticals Inc. stockRobust investment performance - jammulinksnews.com
Amphastar Pharmaceuticals Inc. Stock Analysis and ForecastFastest-growing stock picks - jammulinksnews.com
Is Amphastar Pharmaceuticals Inc. a good long term investmentTriple-digit growth rates - jammulinksnews.com
Hypoglycemia Pipeline 2025: Key Companies, MOA, ROA, - openPR.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 12-Month LowWhat's Next? - MarketBeat
Hussman Strategic Advisors Inc. Makes New Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
What drives Amphastar Pharmaceuticals Inc. stock priceExceptional stock performance - printweek.in
Teacher Retirement System of Texas Lowers Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (AMPH) Plunges 4.98% on Strong Sell Rating - AInvest
agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know - Yahoo Finance
Amphastar Unveils Plans To Quadruple US Manufacturing - insights.citeline.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 52-Week LowHere's What Happened - MarketBeat
Principal Financial Group Inc. Purchases 4,669 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
JPMorgan Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral from Overweight, Brings PT Down to $30 - MSN
Amphastar lays out plan to quadruple manufacturing capacity at its California HQ - Fierce Pharma
What makes Amphastar Pharmaceuticals Inc. stock price move sharplyFree Premium Stock Market Reports - Newser
Why Amphastar Pharmaceuticals Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser
Amphastar to Quadruple Domestic Manufacturing - Association for Accessible Medicines
How Amphastar Pharmaceuticals Inc. stock performs during market volatilityFree Stock Investment Discussion Area - Newser
Amphastar stock hits 52-week low at $21.47 amid challenging year - Investing.com Canada
SteelPeak Wealth LLC Buys Shares of 55,795 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar to quadruple production capacity at California headquarters By Investing.com - Investing.com Nigeria
Amphastar to quadruple production capacity at California headquarters - Investing.com Australia
Amphastar Pharmaceuticals Aims to Quadruple Domestic Manufacturing Capacity at Rancho Cucamonga Headquarters - ACCESS Newswire
Amphastar Plans Massive 4X Production Boost: Major US Pharma Manufacturing Expansion Coming by 2028 - Stock Titan
When the Price of (AMPH) Talks, People Listen - news.stocktradersdaily.com
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - MSN
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Cambridge Investment Research Advisors Inc. - Defense World
Allspring Global Investments Holdings LLC Has $434,000 Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):